| RS1571939623 |
KCND3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS1571939827 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS1571939905 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS1571941465 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571941511 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1571941589 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571945476 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1571945537 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571946866 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571947757 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571947978 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1571948114 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1571948194 |
USH2A;USH2A-AS2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571949264 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1571949388 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571950208 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571953381 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571953449 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1571955307 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571955597 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571957148 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571960363 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1571963780 |
EMC1
|
Health Risk |
Likely pathogenic |
— |
| RS1571964338 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease perinatal lethal, Gaucher disease perinatal lethal |
| RS1571965880 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS1571969643 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS1571979607 |
IRF6
|
Health Risk |
Likely pathogenic |
Orofacial cleft 6, susceptibility to |
| RS1571979802 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome 1, Van der Woude syndrome 1 |
| RS1571983348 |
IRF6
|
Health Risk |
Likely pathogenic |
Orofacial cleft 6, susceptibility to |
| RS1571983440 |
IRF6
|
Health Risk |
Pathogenic |
Popliteal pterygium syndrome, Orofacial cleft 6 |
| RS1571986293 |
IRF6
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofacial cleft 6, susceptibility to |
| RS1571995707 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1571999498 |
RIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 8 |
| RS1572001567 |
EMC1
|
Health Risk |
Likely pathogenic |
Cerebellar atrophy, visual impairment |
| RS1572018284 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1572018886 |
HAX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1572019465 |
CACNA1S
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1572020896 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1572023336 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1572027164 |
FLVCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1572031494 |
FLVCR1
|
Health Risk |
Likely pathogenic |
— |
| RS1572033599 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1572035084 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1572035834 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572036396 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572038993 |
CACNA1S
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572039133 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1572039465 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1572040505 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1572042090 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1572042717 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1572042851 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1572048220 |
CACNA1S
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572049461 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572051012 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1572052376 |
LDLRAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1572057140 |
PKLR
|
Health Risk |
Pathogenic |
— |
| RS1572059904 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1572060087 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1572060089 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1572074292 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1572074313 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1572079834 |
COQ8A
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS1572081759 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS1572086894 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088248 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1572088348 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088481 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1572088737 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088775 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088823 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088837 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088853 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572088865 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572089542 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572090079 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hepatocellular carcinoma |
| RS1572090173 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572090305 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572090368 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572091783 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572091831 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572092076 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572092099 |
SERPINC1
|
Health Risk |
Pathogenic |
Deep venous thrombosis, Deep venous thrombosis |
| RS1572092103 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1572092195 |
SERPINC1
|
Health Risk |
Likely pathogenic |
— |
| RS1572096837 |
KCNT2
|
Health Risk |
Likely pathogenic |
Seizure, Developmental and epileptic encephalopathy |
| RS1572101517 |
TRAPPC12
|
Health Risk |
Pathogenic |
— |
| RS1572110097 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS1572112489 |
ACTN2
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1AA, Dilated cardiomyopathy 1AA |
| RS1572119109 |
SCP2
|
Health Risk |
Pathogenic |
Sterol carrier protein 2 deficiency, Sterol carrier protein 2 deficiency |
| RS1572139792 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hyperparathyroidism 1 |
| RS1572140109 |
ACTN2
|
Health Risk |
Likely pathogenic |
Myopathy, distal |
| RS1572142522 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1572142597 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1572143354 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congestive heart failure, Dilated cardiomyopathy 1AA |
| RS1572146630 |
CDC73
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Parathyroid carcinoma |
| RS1572148902 |
ACTN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, congenital |
| RS1572148914 |
ACTN2
|
Health Risk |
Likely pathogenic |
Myopathy, congenital |
| RS1572150469 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1572150584 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |